Detailed information for compound 1910773

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 489.997 | Formula: C27H28ClN5O2
  • H donors: 2 H acceptors: 4 LogP: 3.98 Rotable bonds: 6
    Rule of 5 violations (Lipinski): 1
  • SMILES: N#Cc1c(cccc1c1ccnnc1)Oc1ccc(cc1Cl)C(=O)NC1CC(C)(C)NC(C1)(C)C
  • InChi: 1S/C27H28ClN5O2/c1-26(2)13-19(14-27(3,4)33-26)32-25(34)17-8-9-24(22(28)12-17)35-23-7-5-6-20(21(23)15-29)18-10-11-30-31-16-18/h5-12,16,19,33H,13-14H2,1-4H3,(H,32,34)
  • InChiKey: XLRMULHWFRKNQV-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens enhancer of zeste 2 polycomb repressive complex 2 subunit Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Echinococcus granulosus histone lysine N methyltransferase Ez Get druggable targets OG5_129164 All targets in OG5_129164
Schistosoma mansoni enhancer of zeste ezh Get druggable targets OG5_129164 All targets in OG5_129164
Brugia malayi SET domain containing protein Get druggable targets OG5_129164 All targets in OG5_129164
Loa Loa (eye worm) SET domain-containing protein Get druggable targets OG5_129164 All targets in OG5_129164
Echinococcus multilocularis histone lysine N methyltransferase E(z) Get druggable targets OG5_129164 All targets in OG5_129164
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Echinococcus granulosus histone lysine N methyltransferase Ez 0.0114 0.5 0.5
Echinococcus multilocularis histone lysine N methyltransferase E(z) 0.0114 0.5 0.5
Schistosoma mansoni enhancer of zeste ezh 0.0114 0.5 0.5
Loa Loa (eye worm) SET domain-containing protein 0.0114 0.5 0.5

Activities

Activity type Activity value Assay description Source Reference
Activity (binding) = 7 uM Inhibition of EZH2 in human HeLa cells assessed as reduction in H3K27me3 level ChEMBL. 24900844
EC50 (binding) = 7 uM Inhibition of EZH2 in human HeLa cells assessed as reduction of H3K27me3 and H3K27me2 level after 96 hrs by ELISA method ChEMBL. 25406853
IC50 (binding) = 0.032 uM Inhibition of wild type EZH2 (unknown origin) ChEMBL. 24900844
IC50 (binding) = 0.032 uM Inhibition of EZH2 (unknown origin) using biotinylated nucleosome, H3K27me3 activator and [3H]-SAM incubated for 60 mins by top-count based method ChEMBL. 26189078
IC50 (binding) = 9.5 uM Inhibition of EZH2 in human KARPAS422 cells assessed as global reduction in H3K27me3 level after 10 days by ELISA-based assay ChEMBL. 24900844
IC50 (binding) = 13.4 uM Inhibition of EZH2 in human KARPAS422 cells assessed as global reduction in H3K27me3 level after 7 days by ELISA-based assay ChEMBL. 24900844
IC50 (binding) = 58.3 uM Inhibition of EZH2 in human KARPAS422 cells assessed as global reduction in H3K27me3 level after 4 days by ELISA-based assay ChEMBL. 24900844
permeability (ADMET) = 0.19 ucm/s Passive permeability from apical to basolateral side in human Caco2 cells ChEMBL. 24900844

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

3 literature references were collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.